Literature DB >> 34950345

Catheter Ablation for Persistent Atrial Fibrillation in Class IV Systolic Heart Failure: A Single-Center Case Series.

Aaron Hesselson1, Heather Hesselson2.   

Abstract

Questions remain as to how aggressively catheter ablation for atrial fibrillation may be applied to patients with advanced systolic congestive heart failure, owing to a historic under-representation in multicenter clinical ablation trials. We sought to describe the experience of catheter ablation for persistent atrial fibrillation in Class IV systolic heart failure patients at our institution. All Class IV systolic heart failure patients (left ventricular assist device patients excluded) between 2017 and 2020 referred for radiofrequency ablation were included. Out of 10 patients, 7 agreed to proceed, had restoration of normal sinus rhythm upon completion of the catheter ablation procedure, and of which five (71%) remain in normal rhythm at a mean follow-up of 23 months. Catheter ablation for atrial fibrillation in patients with Class IV chronic systolic heart failure, even on advanced heart failure therapies, is feasible, and can improve heart failure status with maintenance of NSR.

Entities:  

Keywords:  Atrial Fibrillation; Catheter Ablation; Heart Failure

Year:  2021        PMID: 34950345      PMCID: PMC8691287          DOI: 10.4022/jafib.20200428

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN: 1941-6911


  33 in total

1.  Radiofrequency ablation for persistent atrial fibrillation in patients with advanced heart failure and severe left ventricular systolic dysfunction: a randomised controlled trial.

Authors:  Michael R MacDonald; Derek T Connelly; Nathaniel M Hawkins; Tracey Steedman; John Payne; Morag Shaw; Martin Denvir; Sai Bhagra; Sandy Small; William Martin; John J V McMurray; Mark C Petrie
Journal:  Heart       Date:  2010-11-04       Impact factor: 5.994

2.  Five-year outcomes of catheter ablation in patients with atrial fibrillation and left ventricular systolic dysfunction.

Authors:  T Jared Bunch; Heidi T May; Tami L Bair; Victoria Jacobs; Brian G Crandall; Michael Cutler; J Peter Weiss; Charles Mallender; Jeffrey S Osborn; Jeffrey L Anderson; John D Day
Journal:  J Cardiovasc Electrophysiol       Date:  2015-02-11

3.  Long-term single- and multiple-procedure outcome and predictors of success after catheter ablation for persistent atrial fibrillation.

Authors:  Thomas Rostock; Tushar V Salukhe; Daniel Steven; Imke Drewitz; Boris A Hoffmann; Karsten Bock; Helge Servatius; Kai Müllerleile; Arian Sultan; Nils Gosau; Thomas Meinertz; Karl Wegscheider; Stephan Willems
Journal:  Heart Rhythm       Date:  2011-04-13       Impact factor: 6.343

4.  Insights into ablation of persistent atrial fibrillation: Lessons from 6-year clinical outcomes.

Authors:  Stephanie Brooks; Andreas Metzner; Peter Wohlmuth; Tina Lin; Erik Wissner; Roland Tilz; Andreas Rillig; Shibu Mathew; Ardan Saguner; Christian Heeger; Christian Sohns; Karl-Heinz Kuck; Feifan Ouyang
Journal:  J Cardiovasc Electrophysiol       Date:  2018-01-05

5.  Catheter ablation for atrial fibrillation in congestive heart failure.

Authors:  Li-Fern Hsu; Pierre Jaïs; Prashanthan Sanders; Stéphane Garrigue; Mélèze Hocini; Fréderic Sacher; Yoshihide Takahashi; Martin Rotter; Jean-Luc Pasquié; Christophe Scavée; Pierre Bordachar; Jacques Clémenty; Michel Haïssaguerre
Journal:  N Engl J Med       Date:  2004-12-02       Impact factor: 91.245

6.  Milrinone use is associated with postoperative atrial fibrillation after cardiac surgery.

Authors:  Gregory A Fleming; Katherine T Murray; Chang Yu; John G Byrne; James P Greelish; Michael R Petracek; Steven J Hoff; Stephen K Ball; Nancy J Brown; Mias Pretorius
Journal:  Circulation       Date:  2008-09-29       Impact factor: 29.690

7.  Six-Year Clinical Outcomes After Catheter Ablation of Atrial Fibrillation in Patients With Impaired Left Ventricular Function.

Authors:  Andreas Rillig; Hisaki Makimoto; Jascha Wegner; Tina Lin; Christian Heeger; Christine Lemes; Thomas Fink; Andreas Metzner; Erik Wissner; Shibu Mathew; Peter Wohlmuth; Karl-Heinz Kuck; Roland Richard Tilz; Feifan Ouyang
Journal:  J Cardiovasc Electrophysiol       Date:  2015-09-03

8.  Pulmonary-vein isolation for atrial fibrillation in patients with heart failure.

Authors:  Mohammed N Khan; Pierre Jaïs; Jennifer Cummings; Luigi Di Biase; Prashanthan Sanders; David O Martin; Josef Kautzner; Steven Hao; Sakis Themistoclakis; Raffaele Fanelli; Domenico Potenza; Raimondo Massaro; Oussama Wazni; Robert Schweikert; Walid Saliba; Paul Wang; Amin Al-Ahmad; Salwa Beheiry; Pietro Santarelli; Randall C Starling; Antonio Dello Russo; Gemma Pelargonio; Johannes Brachmann; Volker Schibgilla; Aldo Bonso; Michela Casella; Antonio Raviele; Michel Haïssaguerre; Andrea Natale
Journal:  N Engl J Med       Date:  2008-10-23       Impact factor: 91.245

9.  Pulmonary vein isolation for the treatment of atrial fibrillation in patients with impaired systolic function.

Authors:  Michael S Chen; Nassir F Marrouche; Yaariv Khaykin; A Marc Gillinov; Oussama Wazni; David O Martin; Antonio Rossillo; Atul Verma; Jennifer Cummings; Demet Erciyes; Eduardo Saad; Mandeep Bhargava; Dianna Bash; Robert Schweikert; David Burkhardt; Michelle Williams-Andrews; Alejandro Perez-Lugones; Ahmad Abdul-Karim; Walid Saliba; Andrea Natale
Journal:  J Am Coll Cardiol       Date:  2004-03-17       Impact factor: 24.094

10.  Long-term follow-up after atrial fibrillation ablation in patients with impaired left ventricular systolic function: the importance of rhythm and rate control.

Authors:  Sotirios Nedios; Philipp Sommer; Nikolaos Dagres; Jedrzej Kosiuk; Arash Arya; Sergio Richter; Thomas Gaspar; Nikolaos Kanagkinis; Borislav Dinov; Christopher Piorkowski; Andreas Bollmann; Gerhard Hindricks; Sascha Rolf
Journal:  Heart Rhythm       Date:  2013-12-27       Impact factor: 6.343

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.